1 / 20

Haemostasis

Haemostasis. Prof. K. Sivapalan. Thrombocytes. 2 – 4 μ m in diameter. Half life – 4 days. 300,000 / μ L. Break off from megakaryocytes. Colony stimulating factors and thrombopoietin- liver and kidney. 60 – 70 % in circulating blood - balance in spleen. Properties of Platelets.

razi
Download Presentation

Haemostasis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Haemostasis Prof. K. Sivapalan

  2. Thrombocytes • 2 – 4 μm in diameter. • Half life – 4 days. • 300,000 / μL. • Break off from megakaryocytes. • Colony stimulating factors and thrombopoietin- liver and kidney. • 60 – 70 % in circulating blood - balance in spleen. Haemostasis

  3. Properties of Platelets • A ring of microtubules in periphery. • Extensively invaginated membrane. • Membrane contains receptors for: • Collagen, von Willebrand factor and fibrin. • Dense granules in cytoplasm: • Serotonin, ADP, other nuclear tides. • α – granules in cytoplasm : • Clotting factors and platelet-derived growth factor [PDGF – stimulates wound healing and mitogen for vascular smooth muscle.] Haemostasis

  4. Platelet activation. • Binds to exposed collagen and von Willebrand factor (when damage to blood vessel). This is platelet adhesion. • This activates platelets [ADP] • Platelets change shape, put out psudopodia and release granules and causes platelet aggregation. Haemostasis

  5. Changes in the platelet. • Platelet activation results in change in shape, putting out psseudopodia, release of granules and aehesion to other platelets. • Platelet Activating Factor secreted by neutrophils and monocytes stimulates G protein which activates phospholipase C to form diacylglycerol. This also causes release of granules. • Increased cytoplasmic calcium and diacylglycerol activate Phospholipase A2. This causes release of arachidonic acid from membrane phospholipids which is converted into Thromboxan A2 • Thromboxan and other substances released cause vasoconstriction, platelet aggregation, clot formation • Aspirin prevents the above reaction and alters the balance between thromboxan and prostacycline and prevents clotting in low doses. Haemostasis

  6. Effects of platelet aggregation. • Repair of the blood vessels. • Block damaged capillaries. • Vasoconstriction. • Clotting. • [Test for platelet function: bleeding time.] Haemostasis

  7. Thrombocytopenia. • Results in capillary bleeding [purpura]. • Caused by- • Marrow disorders. • Alcohol, cytotoxic drugs, viral infections. • Hereditary. • Immunologically mediated destruction. • Increased consumption of platelets. Haemostasis

  8. Thrombocytosis. Causes: • Spleanectomy. • Postoperatively, delivery. • Haemorrhage or haemolysis. • Extreme exercise. Risk: • Thrombotic diseases- deep vein thrombosis. Haemostasis

  9. Hemostasis. • Vascular spasm: local myogenic, serotonin – lasts for about 20 – 30 minutes. • Platelet plug. • Clotting of blood. • Organization by fibrous tissue. Haemostasis

  10. Coagulation of blood – clotting. • Fibrinogen → Fibrin. • Polymerization of fibrin with branching. • Loose mesh of interlacing strands. • Formation of covalent bonds → dense, tight aggrigate. Haemostasis

  11. Important reactions. Clot retraction. [platelets] 30 – 60 min. Stabilization. Fibrin. Fibrinogen Activated XIII Thrombin Platelet Factor, Ca++, Activated Factor V. Factor XIII Intrinsic system. 2 – 5 minutes. Factor x (activated) Extrinsic system. 15 – 30 Seconds. Prothrombin Haemostasis

  12. Coagulation cascade. Tissue factor – Extrinsic system. [Tissue Thromboplastin- TPL+TFI] Contact with wettable, negatively charged surface – Intrinsic system. Activated VIII, Platelet factor (PL), Ca++ Ca++TPL+TFI Prekallikerin Kallikerin. HMW Kilinogen XII XIIa. XI XIIa IX IXa VIIa VII Ca++, PL, TPL X Xa Haemostasis

  13. Role of liver in clotting. • Synthesizes: • Fibrinogen. • Prothrombin. • Other clotting factors. • Needs: • Vitamin K. • Removes activated clotting factors. Haemostasis

  14. Propagation of clot formation. • Clot formation can be initiated at any vessel by damage to endothelium by platelet plug. • Activated clotting factors on the surface of the clot can cause further clotting. • Platelet plug can form on the surface of the clot which can initiate further clotting • Rapid flow wash off the factors which are diluted and removed in liver. Haemostasis

  15. Clotting and Anti clotting mechanisms. • Clotting and anti clotting mechanisms are balanced under normal circumstances. • It is essential to maintain blood in liquid form but prevent loss if the vessels are damaged. Haemostasis

  16. Anti clotting mechanisms. • Anti thrombin III [circulating protease] inactivates activated factors IX,X,XI and XII. Heparin facilitates it. • Prostacycline of Endothelium antagonizes thromboxane A2 of platelets. (aggregation) • Endothelium has thrombomodulin. It’s reaction with thrombin leads to fibrinolysis, inactivation of factor V and VIII. Haemostasis

  17. Fibrinolytic system. Thrombomodulin in endothelium. Binds to Thrombin Prtotein C. Activated protein C.[APC] Inhibitor of tissue plasminogen activator inhibited. VIIIa Inactive VIIIa Va Inactive Va Plasmin. Plasminogen Lyses of fibrin. Tissue plasminogen activator Haemostasis

  18. Abnormalities of clotting. Defective clotting: • Abnormalities of platelet function. • Congenital deficiency of clotting factors- • Hemophelia A – factor VIII [ X linked]. • Hemophelia B – factor IX. • Von Willebrand factor deficiency. • Vitamin K deficiency and Liver diseases. Enhanced clotting: • Increased platelets. • Absent Protein C. Intravascular Clotting is thrombosis and if carried in blood it is embolism. Both can obstruct blood vessels and cause ischemia to organs. Haemostasis

  19. Anticoagulants. • Heparin promotes antithrombin III which inactivates factors IX, X, XI and XII. • Warfarin inhibits Vitamin K. • Streptokinase activates plasminogen and disolves fibrin. [snake, bacteria] • Aspirin reduces thromboxan A2 formation. Haemostasis

  20. Investigations. • Clotting time. • Allow blood to clot and record time. • Prothrombin time. • Anticoagulated blood and prothrombin. Add calcium chloride and record time. • Bleeding time. • Time taken to stop bleeding. Haemostasis

More Related